INOVIO PHARMACEUTICALS, INC. — Form D
INOVIO PHARMACEUTICALS, INC. of Plymouth Meeting, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-15. The offering totals $15.2M, of which $15.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-15
- Form: D
- Accession: 0001055726-19-000054
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.2M
- Amount sold: $15.2M
- Investors: 14
- Date of first sale: 2019-08-01
- Security types: debt
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-346682
Issuer
- Name: INOVIO PHARMACEUTICALS, INC.
- CIK: 0001055726
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 660 W. Germantown Pike, Plymouth Meeting, PA, 19462
- Phone: 2674404200
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Morton X Collins | Director | Plymouth Meeting, PA |
| Ann C Miller | Director | Newton, MA |
| Laurent S Humeau | Executive Officer | Plymouth Meeting, PA |
| J. Jospeh Kim | Director | Plymouth Meeting, PA |
| J. Jospeh Kim | Executive Officer | Plymouth Meeting, PA |
| Peter Jospeh Kies | Executive Officer | Plymouth Meeting, PA |
| Angel X Cabrera | Director | Plymouth Meeting, PA |
| Simon X Benito | Director | Plymouth Meeting, PA |
| Jacqueline S Shea | Executive Officer | Plymouth Meeting, PA |
| David B Weiner | Director | Plymouth Meeting, PA |
| Jay X Shepard | Director | Plymouth Meeting, PA |
| Lota S Zoth | Director | La Jolla, CA |
| Wendy L Yarno | Director | Charlottesville, VA |
Other filings by this issuer (1)
More